Abstract
Herein we review commercial bovine lactoferrin quality issues by describing an example of industrial production, the current status of global quality standardization, and quality-activity concerns for further discussion. Morinaga Milk Industry has been industrially producing bovine lactoferrin in Milei GmbH, Germany, since 1989. We delineate its production and quality as an example of safe and high-quality manufacturing. Currently, global standardization in the quality of bovine lactoferrin is progressing through Novel Food and GRAS in the EU and USA, respectively. Novel Food was applied or notified to seven lactoferrin manufacturers and GRAS was notified to three manufacturers, two of which are for infant use and one is for adult use, by the end of 2017. The specifications of these regulations are relatively high, including more than 95% lactoferrin purity in protein, which means that such companies can supply relatively high-grade lactoferrin. There appear to be several concerns regarding lactoferrin quality affecting activities, including contamination of lipopolysaccharide (LPS) and angiogenin, purity, and degradation of lactoferrin sample. Although LPS is immunologically toxic when invading the body, it is distributed normally in foods and the gut. However, an industrial lactoferrin sample may contain LPS at a maximum LPS/lactoferrin molecule ratio = 1/1724, which means 99.9% of the lactoferrin molecule is LPS-free. It is difficult to speculate that LPS contained in a lactoferrin sample affects its activities. Finally in order to achieve good and reproducible results, we make proposals to researchers a use of high-grade lactoferrin, careful storage, and indication the manufacturers’ names and specifications in the paper.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M (2001) Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167:1609–1616
Bharadwaj S, Naidu TAG, Betageri GV, Prasadarao NV, Naidu AS (2010) Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women. Inflamm Res 59:971–978
Chinen T, Komai K, Muto G, Morita R, Inoue N, Yoshida H, Sekiya T, Yoshida R, Nakamura K, Takayanagi R, Yoshimura A (2011) Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance. Nat Commun 2:190
Cutone A, Rosa L, Lepanto MS, Scotti MJ, Berlutti F, Patti MCB, Musci G, Valenti P (2017) Lactoferrin efficiently counteracts the inflammation-induced changes of the iron homeostasis system in macrophages. Front Immunol 8:705
European Commission (2018) Novel Food. What is Novel Food? https://ec.europa.eu/food/safety/novel_food_en. Accessed 24 Jan 2018
Hayashi M, Tanaka N (2005) Genotoxicity of 43 existing food additives. Food Hyg Saf Sci 46:177–184 (in Japanese)
Iigo M, Shimamura M, Matsuda E, Fujita K, Nomoto H, Satoh J, Kojima S, Alexander DB, Moore MA, Tsuda H (2004) Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. Cytokine 25:36–44
Ionova II, Komolova GS, Shalygina AM, Esipova LN (2001) Angiogenin content in human milk in the early period of lactation. Vopr Pitan 70:7–9 (in Russian)
Kozu T, Iinuma G, Ohashi Y, Saito Y, Akasu T, Saito D, Alexander DB, Iigo M, Kakizoe T, Tsuda H (2009) Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res 2:975–983
Lonnerdal B (2011) Biological effects of novel bovine milk fractions. In: Clemens RA, Hernell O, Michaelsen KF (ed) Milk and milk products in human nutrition, vol 67. Nestle Nutrition Workshop Series. Paediatric Programme. S. Karger, Basel, pp 41–54
Miyake M, Goodison S, Lawton A, Gomes-Giacoia E, Rosser CJ (2015) Angiogenin promotes tumoral growth and angiogenesis by regulation matrix metallopeptidase-2 expression via the ERK1/2 pathway. Oncogene 34:890–901
Murata M, Wakabayashi H, Yamauchi K, Toida T, Iwatsuki K (2009) Influence of lipopolysaccharides on the antimicrobial activity of lactoferrin against Escherichia coli. In: IX international conference on lactoferrin, structure, function & applications, program & abstracts, p 43
Murata M, Wakabayashi H, Yamauchi K, Abe F (2013) Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin. J Dairy Sci 96:4891–4898
Na YJ, Han SB, Kang JS, Yoon YD, Park S, Kim HM, Yang K, Joe CO (2004) Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int Immunopharmacol 4:1187–1199
Okada S, Tanaka K, Sato T, Ueno H, Saito S, Okusaka T, Sato K, Yamamoto S, Kakizoe T (2002) Dose-response trial of lactoferrin in patients with chronic hepatitis C. Jpn J Cancer Res 93:1063–1069
Perraudin J-P (2017) Industrial purification of lactoferrin: characterization and quality control. In: XIII international conference on lactoferrin, structure, function & applications, abstract book, p 17
Rosa L, Cutone A, Lepanto MS, Scotti M, Berlutti F, Paesano R, Valenti P (2017) Physico-chemical properties influence the functions and efficacy of commercial bovine lactoferrins. In: XIII international conference on lactoferrin, structure, function & applications, abstract book, p 19
Rustam’ian IL, Shalygina AM, Tikhomirova NA, Rabinovich ML, Pleshanov AN, Komolova GS (1999) Immunoenzyme analysis of angiogenin in cow’s milk. Prikl Biokhim Mikrobiol 35:105–108 (in Russian)
Tomita M, Wakabayashi H, Shin K, Yamauchi K, Yaeshima T, Iwatsuki K (2009) Twenty-five years of research on bovine lactoferrin applications. Biochimie 91:52–57
Townsend S, Caubilla Barron J, Loc-Carrillo C, Forsythe S (2007) The presence of endotoxin in powdered infant formula milk and the influence of endotoxin and Enterobacter sakazakii on bacterial translocation in the infant rat. Food Microbiol 24:67–74
U.S. Food & Drug Administration (2018) Generally recognized as safe (GRAS). https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/default.htm. Accessed 24 Jan 2018
Wakabayashi H, Yamauchi K, Takase M (2006) Lactoferrin research, technology and applications. Int Dairy J 16:1241–1251
Yamauchi K, Toida T, Kawai A, Nishimura S, Teraguchi S, Hayasawa H (2000a) Mutagenicity of bovine lactoferrin in reverse mutation test. J Toxicol Sci 25:63–66
Yamauchi K, Toida T, Nishimura S, Nagano E, Kusuoka O, Teraguchi S, Hayasawa H, Shimamura S, Tomita M (2000b) 13-week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem Toxicol 38:503–512
Acknowledgements
Funding was provided by Morinaga Milk Industry Co., Ltd.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wakabayashi, H., Yamauchi, K. & Abe, F. Quality control of commercial bovine lactoferrin. Biometals 31, 313–319 (2018). https://doi.org/10.1007/s10534-018-0098-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-018-0098-2